| Date Filed | Type | Description |
| 08/10/2023 |
4
| Sharp Aric R (CEO of Value-Based Care) has filed a Form 4 on CLOVER HEALTH INVESTMENTS, CORP. /DE|
Txns:
| Paid exercise price by delivering 7,037 shares
@ $1.39, valued at
$9.8k
|
|
| 08/09/2023 |
4
| Toy Andrew (CEO) has filed a Form 4 on CLOVER HEALTH INVESTMENTS, CORP. /DE|
Txns:
| Paid exercise price by delivering 277,720 shares
@ $1.33, valued at
$369.4k
|
|
| 08/08/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/08/2023 |
8-K
| Quarterly results |
| 08/03/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 08/03/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 07/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 07/21/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 07/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/07/2023 |
SC 13G/A
| BlackRock Inc. reports a 2% stake in CLOVER HEALTH INVESTMENTS CORP CLA |
| 06/30/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 06/16/2023 |
4
| Reynoso Jamie L. (CEO of Medicare Advantage) has filed a Form 4 on CLOVER HEALTH INVESTMENTS, CORP. /DE|
Txns:
| Paid exercise price by delivering 7,776 shares
@ $0.94, valued at
$7.3k
|
|
| 06/16/2023 |
4
| Martin Joseph Richards (General Counsel) has filed a Form 4 on CLOVER HEALTH INVESTMENTS, CORP. /DE|
Txns:
| Paid exercise price by delivering 98,827 shares
@ $0.94, valued at
$92.9k
|
|
| 06/16/2023 |
4
| Wai Conrad (Chief Technology Officer) has filed a Form 4 on CLOVER HEALTH INVESTMENTS, CORP. /DE|
Txns:
| Paid exercise price by delivering 86,763 shares
@ $0.94, valued at
$81.6k
|
|
| 06/16/2023 |
4
| Sharp Aric R (CEO of Value-Based Care) has filed a Form 4 on CLOVER HEALTH INVESTMENTS, CORP. /DE|
Txns:
| Paid exercise price by delivering 28,148 shares
@ $0.93, valued at
$26.2k
|
|
| 06/08/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 06/08/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/16/2023 |
4
| Kouzoukas Demetrios L. (Director) has filed a Form 4 on CLOVER HEALTH INVESTMENTS, CORP. /DE|
Txns:
| Granted 36,585 shares
@ $0 |
|
| 05/09/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/09/2023 |
8-K
| Quarterly results |
| 04/28/2023 |
4
| Garipalli Vivek (Executive Chairperson) has filed a Form 4 on CLOVER HEALTH INVESTMENTS, CORP. /DE|
Txns:
| Paid exercise price by delivering 1,569,594 shares
@ $1.01, valued at
$1.6M
Exercised 3,342,698 restricted stock units
@ $0
Exercised 3,342,698 options to buy
@ $0
Exercised 1,569,594 options to buy
@ $0 |
|
| 04/27/2023 |
3/A
| Form 3/A - Initial statement of beneficial ownership of securities: [Amend] |
| 04/26/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 04/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/26/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/26/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/26/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 04/24/2023 |
8-K
| Quarterly results |
| 04/21/2023 |
8-K
| Quarterly results |
| 04/20/2023 |
8-K
| Quarterly results |
| 04/03/2023 |
3
| Wai Conrad (Chief Technology Officer) has filed a Form 3 on CLOVER HEALTH INVESTMENTS, CORP. /DE |
| 03/17/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
|